SCHEMBL4679623

SCHEMBL4679623

COc1ccc(C2=NC(c3ccc(OC)cc3)C(c3ccc(OC)cc3)N2)cc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 2/20 0.58
TGFBR1 P36897 1/20 0.51
MDM2 Q00987 1/20 0.51
ALDH1A1 P00352 5/20 0.48
MAPT P10636 3/20 0.48
KDM4E B2RXH2 3/20 0.43
GAA P10253 3/20 0.43
NISCH Q9Y2I1 1/20 0.41
RAB9A P51151 1/20 0.38
KMT2A Q03164 2/20 0.38
HPGD P15428 1/20 0.38
ALOX12 P18054 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
SCN4A P35499 1/20 0.37
MEN1 O00255 1/20 0.36
PTGIR P43119 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9578263 1.00 P2RX7 (0.58) P2RX7TGFBR1MDM2ALDH1A1MAPT
SCHEMBL9578261 1.00 P2RX7 (0.58) P2RX7TGFBR1MDM2ALDH1A1MAPT
SCHEMBL9578249 1.00 P2RX7 (0.58) P2RX7TGFBR1MDM2ALDH1A1MAPT
SCHEMBL9578256 1.00 P2RX7 (0.58) P2RX7TGFBR1MDM2ALDH1A1MAPT
SCHEMBL4696045 0.93 MDM2 (0.61) P2RX7TGFBR1MDM2ALDH1A1MAPT
SCHEMBL15099554 0.93 P2RX7 (0.51) P2RX7TGFBR1MDM2ALDH1A1MAPT
SCHEMBL14160015 0.93 MDM2 (0.61) P2RX7TGFBR1MDM2ALDH1A1MAPT
SCHEMBL15096110 0.88 P2RX7 (0.47) P2RX7TGFBR1MDM2ALDH1A1MAPT
SCHEMBL4680050 0.82 MDM2 (0.51) P2RX7TGFBR1MDM2MAPTKDM4E
SCHEMBL4677500 0.82 MDM2 (0.51) P2RX7TGFBR1MDM2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0433682-A2 Use of 2,4,5-tri(4-methoxyphenyl)-4,5-dihydroimidazole for the treatment of cancer MARION MERRELL DOW INC. (US) 1991-06-26 EP claimed
JP-3170424-A None JP disclosed
EP-1458380-B1 CIS-2,4,5- TRIPHENYL-IMIDAZOLINES AND THEIR USE IN THE TREATMENT OF TUMORS HOFFMANN LA ROCHE (CH) 2008-03-19 EP disclosed
US-5182268-A Pharmaceutical composition comprising daunorubicin potentiated with 2,4,5-tri (4-methoxyphenyl)-4,5-dihydroimidazole MARION MERRELL DOW, INC. (US) 1993-01-26 US disclosed
US-5182268-A Pharmaceutical composition comprising daunorubicin potentiated with 2,4,5-tri (4-methoxyphenyl)-4,5-dihydroimidazole MARION MERRELL DOW, INC. (US) 1993-01-26 US disclosed
EP-0433682-A3 USE OF 2,4,5-TRI(4-METHOXYPHENYL)-4,5-DIHYDROIMIDAZOLE FOR THE TREATMENT OF CANCER 1992-02-26 EP disclosed
JP-H03170424-A TREATMENT OF CANCER MARION MERRELL DOW INC 1991-07-24 JP disclosed
EP-0433682-A2 Use of 2,4,5-tri(4-methoxyphenyl)-4,5-dihydroimidazole for the treatment of cancer MARION MERRELL DOW INC. (US) 1991-06-26 EP disclosed
EP-0433682-A2 Use of 2,4,5-tri(4-methoxyphenyl)-4,5-dihydroimidazole for the treatment of cancer MARION MERRELL DOW INC. (US) 1991-06-26 EP disclosed
EP-0433682-A2 Use of 2,4,5-tri(4-methoxyphenyl)-4,5-dihydroimidazole for the treatment of cancer MARION MERRELL DOW INC. (US) 1991-06-26 EP disclosed